Fate Therapeutics
Price & Volume
Stats
See more52W Range | $1.04-$8.83 |
Market Cap | $144.6M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $13.4M |
Revenue Growth (YoY) | 58.1% |
Gross Profit (12 Mos) | -$108.8M |
Diluted EPS | -$1.64 |
News
See moreYahoo Finance • 6 months ago
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
Yahoo Finance • 8 months ago
Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
Yahoo Finance • 11 months ago
Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price Targets
Yahoo Finance • 11 months ago
Fate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial Results
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 181 |
